Washington, D.C. – Late last night, Sens. Orrin Hatch, R-Utah, and Sheldon Whitehouse, D-R.I., introduced bipartisan legislation that would enable the Drug Enforcement Administration (DEA) to better enforce selective androgen receptor modulators, otherwise known as SARMs. The SARMs Control Act of 2018 builds on the success of the Designer Anabolic Steroid Control Act (DASCA) of 2014 by enhancing the DEA’s authority to protect consumers by removing illegal SARMs substances from the market. SARMs are associated with serious safety concerns, including the potential to increase the risk of heart attack or stroke and life-threatening reactions like liver damage. They are not approved by the Food and Drug Administration (FDA) for human use, are illegally marketed and sold as dietary supplements, and are banned in all professional and college sports. Members of the dietary supplement (DS) industry are applauding this legislation. The United Natural Products Alliance (UNPA) joined with the other major DS trade associations – American Herbal Products Association (AHPA), Council for Responsible Nutrition (CRN) and Consumer Healthcare Products Association (CHPA) – as well as the U.S. Anti...